Interleukin-2 allows in vivo induction of anti-erythrocyte autoantibody production in nude mice associated with the injection of rat erythrocytes
- PMID: 6974628
- PMCID: PMC1537175
Interleukin-2 allows in vivo induction of anti-erythrocyte autoantibody production in nude mice associated with the injection of rat erythrocytes
Abstract
Mice injected with rat red blood cells developed anti-erythrocyte autoantibodies detectable by a direct Coombs' test. Nude mice injected with rat red blood cells did not develop a Coombs-positive state, but nude mice injected with rat red blood cells plus the T cell helper factor, interleukin-2, produced autoantibodies to autologous mouse erythrocytes. The simultaneous injection of rat red blood cells and allogeneic spleen cells induced an early and vigorous autoantibody response in athymic nude mice as well as in euthymic control mice. These results are interpreted as indicating the possibility of an interleukin-2-stimulated in vivo differentiation (or clonal expansion) of helper T cells in nude mice in response to heterologous erythrocytes which could mediate an autoimmune B cell response.
Similar articles
-
Anti-erythrocyte autoantibody production in mice associated with the injection of rat erythrocytes.Immunology. 1980 Apr;39(4):469-79. Immunology. 1980. PMID: 6445870 Free PMC article.
-
Expression and regulation of erythrocyte auto-antibodies in mice following immunization with rat erythrocytes.Eur J Immunol. 1989 May;19(5):795-801. doi: 10.1002/eji.1830190503. Eur J Immunol. 1989. PMID: 2525473
-
Experimental erythrocyte autoimmunity. II. Autoantibody-specific suppressor cells present in blood.Int Arch Allergy Appl Immunol. 1980;62(2):227-30. Int Arch Allergy Appl Immunol. 1980. PMID: 6445340
-
Anti-red blood cell autoantibody transgenic mice: murine model of autoimmune hemolytic anemia.Semin Immunol. 1996 Feb;8(1):3-9. doi: 10.1006/smim.1996.0002. Semin Immunol. 1996. PMID: 8850293 Review.
-
Breakage of B cell tolerance and autoantibody production in anti-erythrocyte transgenic mice.Int Rev Immunol. 1999;18(3):259-70. doi: 10.3109/08830189909043029. Int Rev Immunol. 1999. PMID: 10614728 Review.
Cited by
-
Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.J Exp Med. 1985 May 1;161(5):1169-88. doi: 10.1084/jem.161.5.1169. J Exp Med. 1985. PMID: 3886826 Free PMC article.
-
Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation.J Inflamm Res. 2010;3:143-70. doi: 10.2147/JIR.S9425. Epub 2010 Dec 2. J Inflamm Res. 2010. PMID: 22096364 Free PMC article.
-
Suppressive and augmentative effects of recombinant human interleukin-2 upon delayed type of hypersensitivity in the mouse.Inflammation. 1986 Jun;10(2):167-74. doi: 10.1007/BF00915998. Inflammation. 1986. PMID: 3486827
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources